beta

ADMS

Adamas Pharmaceuticals Inc.

Adms

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Adamas Pharmaceuticals Inc is a pharmaceutical company focused on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The Company is developing its wholly-owned product candidate, ADS-5102.

Market Cap: 951 Million

Primary Exchange: NASDAQ Global Market

Website: http://www.adamaspharma.com

Shares Outstanding: 22.8 Million

Float: 22.4 Million

Dividend: 0.0 (0.0%)

Beta: 1.335078

Sector: Healthcare

Industry: Drug Manufacturers

Short Interest (Jan 12, 2018): 7.42 Million

Ethical Flags

Animal testing

Longest drawdown: 481 trading days

From: 2015-12-23 To: 2017-11-20

Lowest Point:

ADMS INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Adamas Pharmaceuticals, Inc.

via: Business Wire at 2019-06-10 05:00:00:000

The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been filed on behalf of investors who purchased the common stock of Adamas Pharmaceuticals, Inc. (Adamas or the Company) (Nasdaq: ADMS) directly in the Com… read more...

ADMS INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Adamas Pharmaceuticals, Inc.

via: Business Wire at 2019-06-10 05:00:00:000

The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been filed on behalf of investors who purchased the common stock of Adamas Pharmaceuticals, Inc. (Adamas or the Company) (Nasdaq: ADMS) directly in the Com… read more...

ADMS INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Adamas Pharmaceuticals, Inc.

via: Business Wire at 2019-06-10 05:00:00:000

The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been filed on behalf of investors who purchased the common stock of Adamas Pharmaceuticals, Inc. (Adamas or the Company) (Nasdaq: ADMS) directly in the Com… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud